JournalsHub
.online
Find My Journal
RD

Reynald Dupuis

Pfizer (France) FR

5
Publications
970
Citations
4
H-Index
4
i10-Index
0
2yr Mean Cite
True
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions
P Simon, Reynald Dupuis, Jean Costentin
Behavioural Brain Research 1994
768
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux
Maryse Guérin, Pascal Egger, Céline Soudant, Wilfried Le Goff, Arie van Tol +2 more
Atherosclerosis 2002
100
Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state OA
Maryse Guérin, Pascal Egger, Céline Soudant, Wilfried Le Goff, Arie van Tol +2 more
Journal of Lipid Research 2002
66
Atorvastatin Reduces Postprandial Accumulation and Cholesteryl Ester Transfer Protein-Mediated Remodeling of Triglyceride-Rich Lipoprotein Subspecies in Type IIB Hyperlipidemia OA
Maryse Guérin, Pascal Egger, Wilfried Le Goff, Céline Soudant, Reynald Dupuis +1 more
The Journal of Clinical Endocrinology & Metabolism 2002
32
Comparison of achievement of treatment targets as perceived by physicians and as calculated after implementation of clinical guidelines for the management of hypercholesterolemia in a randomized, clinical trial
Gerard K. Nguyen, J. M. Cruickshank, Anne Mouillard, Marie-Laure Dumuis, Carole Picard +5 more
Current Therapeutic Research 2000
4

Publications

5 total

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

Maryse Guérin, Pascal Egger, Céline Soudant, Wilfried Le Goff, Arie van Tol et al. - Atherosclerosis, 2002
Cited by 100 OpenAlex

Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state PDF

Maryse Guérin, Pascal Egger, Céline Soudant, Wilfried Le Goff, Arie van Tol et al. - Journal of Lipid Research, 2002
Cited by 66 OpenAlex

Atorvastatin Reduces Postprandial Accumulation and Cholesteryl Ester Transfer Protein-Mediated Remodeling of Triglyceride-Rich Lipoprotein Subspecies in Type IIB Hyperlipidemia PDF

Maryse Guérin, Pascal Egger, Wilfried Le Goff, Céline Soudant, Reynald Dupuis et al. - The Journal of Clinical Endocrinology & Metabolism, 2002
Cited by 32 OpenAlex

Comparison of achievement of treatment targets as perceived by physicians and as calculated after implementation of clinical guidelines for the management of hypercholesterolemia in a randomized, clinical trial

Gerard K. Nguyen, J. M. Cruickshank, Anne Mouillard, Marie-Laure Dumuis, Carole Picard et al. - Current Therapeutic Research, 2000
Cited by 4 OpenAlex

Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions

P Simon, Reynald Dupuis, Jean Costentin - Behavioural Brain Research, 1994
Cited by 768 OpenAlex

Research Topics

Diabetes, Cardiovascular Risks, and Lipoproteins (3) Lipoproteins and Cardiovascular Health (3) Cholesterol and Lipid Metabolism (2) Neurotransmitter Receptor Influence on Behavior (1) Computational Drug Discovery Methods (1)

Frequent Co-Authors

MA
Maryse Guérin
3 joint publications
PA
Pascal Egger
3 joint publications
CÉ
Céline Soudant
3 joint publications
WI
Wilfried Le Goff
3 joint publications
AR
Arie van Tol
2 joint publications
P
P Simon
1 joint publication

Affiliations

Centre National de la Recherche Scientifique
FR 1994 - 1994
Pfizer (France)
FR 2002 - 2002
Université de Rouen Normandie
FR 1994 - 1994

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now